Traws Pharma, Inc. Amortization of Debt Issuance Costs
Traws Pharma, Inc. (TRAW) reported Amortization of Debt Issuance Costs of $15.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2015-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2015-03-30
- Traws Pharma, Inc. amortization of debt issuance costs for the quarter ending 2012-12-31 was $0.00.
- Traws Pharma, Inc. amortization of debt issuance costs for fiscal 2012 was $15.00K, a 28.57% decline from fiscal 2011.
- Traws Pharma, Inc. amortization of debt issuance costs for fiscal 2011 was $21.00K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $15.00K 10-K · filed 2015-03-30 | |
| 2012-09-30 | $15.00K 10-Q · filed 2013-11-14 | ||
| 2011-12-31 | $21.00K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |